Study on the Effect of Apatinib Salvage Treatment of Advanced Non-Small Cell Lung Cancer

被引：0
|
作者：
Xu, Z. [1 ]
Xu, C. [2 ]
Wang, W. [3 ]
Xu, Q. [4 ]
Zhuang, W. [5 ]
Song, Z. [3 ]
Zhu, Y. [6 ]
Shi, M. [7 ]
Chen, G. [2 ]
Fang, M. [3 ]
Lv, T. [8 ]
Song, Y. [8 ]
机构：
[1] Fujian Prov Canc Hosp, Fuzhou, Fujian, Peoples R China
[2] Fujian Prov Canc Hosp, Pathol, Fuzhou, Fujian, Peoples R China
[3] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[4] Fujian Med Univ, Fujian Union Hosp Affiliated, Fuzhou, Fujian, Peoples R China
[5] Fujian Prov Canc Hosp, Med Oncol, Fuzhou, Fujian, Peoples R China
[6] Zhejiang Rongjun Hosp, Chest Dis Diag & Treatment Ctr, Jiaxing, Peoples R China
[7] Chinese Acad Sci, Canc Hosp, Hefei, Anhui, Peoples R China
[8] Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp Med, Nanjing, Jiangsu, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
efficacy; Apatinib; adverse event;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-017
引用
收藏
页码：S2074 / S2074
页数：1
相关论文
共 50 条
  • [41] CRIZOTINIB FOR THE TREATMENT OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Bowles, D. W.
    Weickhardt, A. J.
    Doebele, R. C.
    Camidge, D. R.
    Jimeno, A.
    [J]. DRUGS OF TODAY, 2012, 48 (04) : 271 - 282
  • [42] IMPROVING TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Reck, M.
    [J]. ANTICANCER RESEARCH, 2008, 28 (6B) : 4038 - 4038
  • [43] TREATMENT OF ADVANCED NON-SMALL CELL LUNG-CANCER WITH BISANTRENE
    FUKS, JZ
    VANECHO, DA
    GARBINO, C
    KASDORF, H
    AISNER, J
    [J]. CANCER TREATMENT REPORTS, 1983, 67 (06): : 597 - 598
  • [44] The safety of nivolumab for the treatment of advanced non-small cell lung cancer
    Metro, Giulio
    Ricciuti, Biagio
    Brambilla, Marta
    Baglivo, Sara
    Soli, Irene
    Minenza, Elisa
    Leonardi, Giulia Costanza
    D'arpino, Alessandro
    Colabrese, Daniela
    Tazza, Marco
    Zicari, Daniela
    Minotti, Vincenzo
    Chiari, Rita
    [J]. EXPERT OPINION ON DRUG SAFETY, 2017, 16 (01) : 101 - 109
  • [45] Immunotherapy in treatment naive advanced non-small cell lung cancer
    Ernani, Vinicius
    Ganti, Apar Kishor
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S412 - S421
  • [46] Novel immunotherapy in the treatment of advanced non-small cell lung cancer
    Santabarbara, G.
    Maione, P.
    Rossi, A.
    Palazzolo, G.
    Gridelli, C.
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (12) : 1571 - 1581
  • [47] Ramucirumab for the treatment of advanced or metastatic non-small cell lung cancer
    Takeda, Koji
    Daga, Haruko
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (12) : 1541 - 1547
  • [48] A Paradigm Shift in the Treatment of Advanced Non-Small Cell Lung Cancer
    Varughese, Shibu
    Jahangir, K. Saad
    Simpson, Catherine E.
    Boulmay, Brian C.
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2012, 344 (02): : 147 - 150
  • [49] The role of pembrolizumab in the treatment of advanced non-small cell lung cancer
    Santabarbara, Giuseppe
    Maione, Paolo
    Rossi, Antonio
    Palazzolo, Giovanni
    Gridelli, Cesare
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (11)
  • [50] Multimodality treatment in advanced stage non-small cell lung cancer
    Klikovits, T.
    Hoda, M. A.
    Ghanim, B.
    Aigner, C.
    Taghavi, S.
    Lang, G.
    Matilla, J.
    Klepetko, W.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2011, 123 (17-18) : A21 - A21
12345